IBD icon

Inspire Corporate Bond ETF

23.48 USD
+0.06
0.26%
At close Dec 20, 4:00 PM EST
After hours
23.48
+0.00
0.00%
1 day
0.26%
5 days
-0.89%
1 month
-0.72%
3 months
-3.33%
6 months
0.17%
Year to date
-0.21%
1 year
-0.34%
5 years
-8.67%
10 years
-6.45%
0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

59% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 22

17% more funds holding in top 10

Funds holding in top 10: 6 [Q2] → 7 (+1) [Q3]

11% more funds holding

Funds holding: 71 [Q2] → 79 (+8) [Q3]

4% more capital invested

Capital invested by funds: $270M [Q2] → $281M (+$10.1M) [Q3]

4.5% less ownership

Funds ownership: 87.13% [Q2] → 82.63% (-4.5%) [Q3]

Research analyst outlook

We haven’t received any recent analyst ratings for IBD.

Financial journalist opinion

Neutral
Zacks Investment Research
1 month ago
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
A smart beta exchange traded fund, the Inspire Corporate Bond ETF (IBD) debuted on 07/10/2017, and offers broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Neutral
Business Wire
1 month ago
Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases
LA JOLLA, Calif.--(BUSINESS WIRE)--As people live longer than ever before, the incidence of aging-related, chronic diseases is on the rise, severely impacting quality of life and placing an unprecedented financial and care burden on overwhelmed families, government agencies and healthcare providers. To help address this growing challenge, scientists at Scripps Research and its nonprofit drug development arm, the Calibr-Skaggs Institute for Innovative Medicines, are advancing novel regenerative.
Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases
Neutral
Zacks Investment Research
3 months ago
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Making its debut on 07/10/2017, smart beta exchange traded fund Inspire Corporate Bond ETF (IBD) provides investors broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Neutral
Zacks Investment Research
5 months ago
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
A smart beta exchange traded fund, the Inspire Corporate Bond ETF (IBD) debuted on 07/10/2017, and offers broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Neutral
Zacks Investment Research
7 months ago
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
The Inspire Corporate Bond ETF (IBD) made its debut on 07/10/2017, and is a smart beta exchange traded fund that provides broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Positive
Investors Business Daily
8 months ago
Funds Keep Loading Up On Nvidia, Meta And Three Other Magnificent Seven Stocks
Nvidia stock is one of 15 stocks funds are buying even as markets come under pressure. Other stocks include Meta, Google, Amazon and Microsoft.
Funds Keep Loading Up On Nvidia, Meta And Three Other Magnificent Seven Stocks
Neutral
Zacks Investment Research
9 months ago
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
The Inspire Corporate Bond ETF (IBD) made its debut on 07/10/2017, and is a smart beta exchange traded fund that provides broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Positive
Seeking Alpha
9 months ago
The Credit Opportunity In M&A
M&A was almost dormant in 2023. In the US, as a proportion of the market value of the benchmark equity indices, it fell to its lowest level in 20 years, according to McKinsey. Credit investors are not traditionally supposed to be fans of M&A, and it's true we are wary of leveraging M&A, where debt is loaded onto balance sheets to buy competitors. We are seeing a comeback for M&A that we think is likely to continue through 2024.
Neutral
Zacks Investment Research
11 months ago
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
The Inspire Corporate Bond ETF (IBD) was launched on 07/10/2017, and is a smart beta exchange traded fund designed to offer broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Charts implemented using Lightweight Charts™